BRANDY HYDE: Open Payments
NPI 1598373110 · HALEYVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 11 payments from 9 companies in 2025. Trend: 2023 $289 · 2024 $215 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $125 |
| ABBVIE INC. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| PFIZER INC. | 1 | $20 |
| Corcept Therapeutics | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: XIFAXAN, CAPLYTA, LINZESS, ELIQUIS, Korlym, JOURNAVX, BREZTRI, UBRELVY.
Industry payments across AL — which companies pay providers there.
